Home Newsfeeds Stifel Maintains Hold on e.l.f. Beauty, Raises Price Target to $50

Stifel Maintains Hold on e.l.f. Beauty, Raises Price Target to $50

Stifel analyst Mark Astrachan maintains e.l.f. Beauty (NYSE:ELF) with a Hold and raises the price target from $43 to $50.

byBenzinga Newsdesk

January 24, 2023

1 minute read

Stifel analyst Mark Astrachan maintains e.l.f. Beauty (NYSE:ELF) with a Hold and raises the price target from $43 to $50.

Analyst Ratings

Expert Ratings for Williams Companies

By Benzinga Insights

August 3, 12:12 PM

Analysts have provided the following ratings for Williams Companies (NYSE:WMB) within the last quarter:

WMB

What’s Going On With Hawaiian Electric Stock?

By Adam Eckert

August 17, 10:35 AM

Hawaiian Electric Industries Inc (NYSE: HE) shares are trading lower following reports the company is facing multiple lawsuits and is in talks

Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court

By Lara Goldstein

March 14, 2:24 PM

Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OTCQB: MSSTF) in the District Court of New Jersey.

MSSTF

Corcept Initiates MONARCH A Phase 2b Trial Of Its Proprietary Selective Cortisol Modulator Miricorilant In Patients With Non-Alcoholic Steatohepatitis

By Benzinga Newsdesk

October 26, 4:45 PM

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating

CORT

Stifel Maintains Hold on e.l.f. Beauty, Raises Price Target to $50

Related Posts

Expert Ratings for Williams Companies

What’s Going On With Hawaiian Electric Stock?

Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court

Corcept Initiates MONARCH A Phase 2b Trial Of Its Proprietary Selective Cortisol Modulator Miricorilant In Patients With Non-Alcoholic Steatohepatitis